RANDEEP GULERIA

Government looks to involve private sector once vaccine drive expands to 50-plus age group

As govt moves to expand the vaccination process to the 50-plus age group, the Centre is looking to rope in the private sector in a major wa...

Herd immunity is 'very difficult' to achieve in India, says AIIMS director Randeep Guleria

Herd immunity is "very difficult" to achieve and one should not think of it in "practical terms" in India, especially in the times of "vari...

AIIMS chief calls for PPP for large-scale rollout of COVID-19 vaccination programme

"We have this small window before things may worsen and therefore we should take whatever vaccine we get and immunise ourselves so that we ...

AIIMS Director Dr Randeep Guleria receives 2nd dose of COVID vaccine

AIIMS Director Dr Randeep Guleria received the second dose of COVID-19 vaccine on February 17. Dr Guleria said that the vaccine will be ava...

Vaccine antibodies will last at least 8 months: AIIMS chief

Dr Guleria added that after two doses, “you are protected. But protecting others would need you to follow Covid-appropriate behaviour”. He ...

IIT Kharagpur to felicitate six luminaries with honorary awards for exemplary contributions to society

This award is conferred as per approval by the Hon’ble President of India on the recommendation of the Institute.

Security guard administered COVID vaccine admitted at AIIMS after developing allergic reaction

According to AIIMS Director Randeep Guleria, the security guard, in his 20s, at AIIMS who received the jab after 4 pm, complained of palpit...

Delhi: AIIMS Director Dr. Randeep Guleria receives Covid-19 vaccine

WATCH | AIIMS Director Dr Randeep Guleria receives COVID-19 vaccine shot at AIIMS, Delhi.Delhi: AIIMS Director Dr. Randeep Guleria receives...

Covid-19 vaccine: Only 'severe' comorbid cases to get priority in phase-I

An expert committee under AIIMS director Randeep Guleria is working on a formula to assess the severity of comorbid conditions for people b...

India’s vaccination drive will start in 7-14 days, says Randeep Guleria

‘Backbone’ of vaccination will be Serum Institute’s Covishield; Bharat Biotech’s Covaxin will be ‘emergency’ backup, says taskforce member

AIIMS director hails DCGI approval of 'India-made' COVID vaccine

"It is a great moment for India and for our fight against COVID-19. Bharat Biotech's Covaxin is a vaccine that has been made in India. A ma...

2 virus mutations per month, no need for alarm: AIIMS director Dr Randeep Guleria

“The mutations have not led to any change in symptoms and treatment strategy. According to current data, the vaccines in the trial phase (w...

Chennai trial finding is incidental rather than related to vaccine: AIIMS Director

"There is good data available that the vaccines are very safe. Safety and efficacy of vaccine not compromised at all. About 70,000-80,000 v...

Huge gap in demand, supply of organs for transplant in country: AIIMS chief

AIIMS Director Dr Randeep Guleria said the AIIMS was working to "very soon" start a lung transplant programme even as it has facilities ava...

Govt undertook 3-pronged approach to tackle COVID-19: Health secretary

Speaking at the inaugural session at Asia Health 2020 organised by the Confederation of Indian Industry, Union Health Secretary said a "who...

Post-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director

"Such issues get resolved in about six weeks in most cases. We advise them to exercise, have a diet with green leafy vegetables and multivi...

COVID-19 is likely to peak in June-July: Randeep Guleria

New Delhi [India], May 7 (ANI) As per the modeling data and the way India's COVID-19 cases are increasing, it is likely that peak can come ...